Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-05-17 @ 3:01 AM
Study NCT ID:
NCT00300105
Status:
TERMINATED
Last Update Posted:
2008-03-17
First Post:
2006-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes
Sponsor:
AstraZeneca
Organization: